PCN222 The Cost of STAGE IV Melanoma with BRAF V600 Mutations in Greece

Autor:	D. Latsou, V. Carayanni, E. Stamuli, H. Gogas, I. Boukovinas, D. Bafaloukos, M. Hatzikou
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty business.industry Health Policy Internal medicine Public Health Environmental and Occupational Health medicine Stage iv melanoma business
Zdroj:	Value in Health. 23:S462
ISSN:	1098-3015
DOI:	10.1016/j.jval.2020.08.359
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b454f44f71aaf971807f4bf1d700c8cf https://doi.org/10.1016/j.jval.2020.08.359 Zobrazit plný text záznamu Full Text from ScienceDirect